Analyst: Bavarian Nordic has an attractive Covid-19 vaccine candidate
New data confirms Bavarian Nordic’s Covid-19 vaccine’s booster potential, as the candidate increased neutralizing antibody levels enough to protect against the virus.
by marketwire, translated by daniel pedersen
Additional data from Bavarian Nordic’s phase II study of its Covid-19 vaccine is positive, assesses Søren Løntoft Hansen, senior equity analyst at Danish bank Sydbank.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian aims for universal Covid-19 booster
For subscribers
.jpg&w=384&q=75)
